NASDAQ:ESPR

Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame
····

Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame

Esperion Therapeutics shares held at $3.13 late Wednesday, just below Archimed’s $3.16-a-share cash offer, as investors assessed closing and milestone risks in the $1.1 billion take-private deal. The stock saw volume above 7 million shares. The merger includes a contingent value right tied to future drug sales. Esperion’s first-quarter revenue rose to $80.1 million, with a net loss narrowing to $25.2 million.
May 20, 2026

Stock Market Today

  • Investing $5,000 Yearly in ASX Shares: Can It Build Wealth?
    May 28, 2026, 4:53 PM EDT. Investing $5,000 annually into ASX shares with an average 9% return, while not guaranteed, can grow significantly due to compounding - where earnings generate their own earnings. After 20 years, such investments could reach around $280,000, and after 30 years, approximately $740,000. At 34 years, the portfolio might surpass $1 million without increasing the annual contribution. Experts recommend a diversified approach, such as using ASX ETFs like Vanguard's MSCI Index International Shares ETF (ASX: VGS), combined with select quality stocks. The key is discipline, patience, and allowing time to harness compounding effects across market cycles.